Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton′s Tyrosine Kinase (BTK), LFM-A13 [α-Cyano-β-Hydroxy-β-Methyl-N-(2,5-Dibromophenyl)Propenamide]
Open Access
- 1 April 1999
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (14), 9587-9599
- https://doi.org/10.1074/jbc.274.14.9587
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Crystal structure of the Src family tyrosine kinase HckNature, 1997
- A License to KillCell, 1996
- BTKbase: a database of XLA-causing mutationsImmunology Today, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Bruton's Tyrosine Kinase is a Key Regulator in B‐Cell DevelopmentImmunological Reviews, 1994
- Mutation of Unique Region of Bruton's Tyrosine Kinase in Immunodeficient XID MiceScience, 1993
- Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemiaCell, 1993
- Synthesis and biological activity of a series of diaryl-substituted .alpha.-cyano-.beta.-hydroxypropenamides, a new class of anthelmintic agentsJournal of Medicinal Chemistry, 1991
- A fast algorithm for rendering space-filling molecule picturesJournal of Molecular Graphics, 1988
- Solvent-Accessible Surfaces of Proteins and Nucleic AcidsScience, 1983